Fever of Unknown Origin: Treatment According to Risk Assessment
Granulocyte count <500/μl or <1,000/μl with predicted decline to ≤500/μl Single oral temperature of >38.3 °C or ≥38.0 °C × 2 within 12 h or ≥38.0 °C over ≥1 h No obvious…
Granulocyte count <500/μl or <1,000/μl with predicted decline to ≤500/μl Single oral temperature of >38.3 °C or ≥38.0 °C × 2 within 12 h or ≥38.0 °C over ≥1 h No obvious…
Fig. 15.1 Targets of systemic antifungal agents Clinical outcomes in susceptible isolates are best predicted by the peak serum level to MIC ratio. Serum drug levels are infrequently measured and…
Risk factor for infection Risk category Low High 1. Pretransplant General condition including organ function Performance status Good Poor Renal failure No Yes Diabetes mellitus No Yes Iron stores…
Bacterial pathogens Streptococcus pneumoniae Haemophilus influenzae Neisseria meningitidis Nocardia species Salmonella species Listeria monocytogenes Campylobacter species Legionella species Capnocytophaga species Mycobacteria Fungal pathogens Aspergillus species Zygomycetes (Mucorales) Fusarium species Scedosporium…
L. monocytogenes a S. pneumoniae Staphylococcus spp. Pseudomonas spp. Gram-negative aerobic bacilli N. meningitidis Candida spp. b Aspergillus spp. Cryptococcus neoformans b Varicella zoster virusc Herpes simplex virusc Cytomegalovirus P….
Duration <1 week: moderate risk >1 week: high risk Absolute neutrophil count (ANC) <1,000/μL: moderate risk <100/μL: high risk However, the term neutropenia is frequently used in clinical practice as…
Fig. 5.1 Frequency of single-agent bacteremia in IATC-EORTC trials Since the turn of the twenty-first century, the reports emerged indicating that GNB have gained importance again but this time with…
Type of prophylaxis and clinical condition Recommendation and gradinga Antibacterial prophylaxis Patients with acute leukemia and adult SCT recipients after myeloablative therapy A fluoroquinolone with systemic activity including P. aeruginosa…